University of Manchester Designated Academic Health Science Centre for Five Years
The University of Manchester Academic Health Science Centre (MAHSCH), part of Health Innovation Manchester, was officially designated by National Institute for Health Research (NIHR), NHS England and NHS Improvement up to 2025. The prestigious Academic Health Science...
The Carrimycin Clinical Trial in China: An Obscure Drug Targeting Upper Respiratory Infection
Beijing Youan Hospital launched a study on February 23, 2020, to investigate the efficacy and safety of a drug developed in China called Carrimycin against COVID-19. Developed for upper respiratory infections among other things, the drug was approved by the National...
Does Lopinavir-Ritonavir Help COVID-19 Patients?
A Lancaster University statistician who worked on the first published large randomized clinical trial for a potential treatment for the COVID-19 virus said it was encouraging to see the scientific community coalescing to combat COVID-19. With no treatments and...
When the Taylors met Dr. Lopez de Castilla, the Possible Occurred Against COVID-19
Josie and George Taylor, 74 and 76 respectively, have been married for almost 52 years and most recently faced one of their biggest challenges in over half a century: COVID-19. After the two recovered while at EvergreenHealth medical center, they were approached by a...
University of Buffalo Commences Sarilumab Clinical Trial for those COVID-19 Patients at Risk for Cytokine Storm
University of Buffalo (UB) and Roswell Park Comprehensive Cancer Center received the greenlight from the U.S. Food and Drug Administration to initial a “collaborative clinical study” using sarilumab to address some adverse COVID-19 effects. The study’s principal...
Francis Suarez Mayor of Miami Becomes First in Florida to Donate his Plasma for Experimental Treatment
Francis Suarez, the Mayor of Miami fell ill to COVID-19 and, thankfully, recovered recently. His initial infection shook up the political establishment in South Florida. Upon recovery, he agreed to donate his plasma, making him first recovered COVID-19 patient in...
GSK Injects $250m into Vir in Collaborative Pact to Develop COVID-19 Treatments
Leveraging its capital, global reach, and functional genomics expertise, GlaxoSmithKline will inject $250 million into Vir Biotechnology, and its proprietary monoclonal antibody platform, as part of a collaboration to develop COVID-19 therapy candidates into Phase II...
Australian Research Team Identifies Ivermectin Zaps COVID-19 in Cell Cultures
Researchers from Monash University’s Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity at Royal Melbourne Hospital recently published the results of a study revealing that Ivermectin, an approved anti-parasitic drug...
Infectious Disease Research Institute Partners with RTP CRO FHI Clinical for COVID-19 Clinical Trial
The Infectious Disease Research Institute (IDRI), a Seattle-based not-for-profit organization, has partnered with a full-service, Research Triangle, NC-based contract research organization called FHI Clinical to support full-service research capabilities for an...
University of Pittsburgh’s Experimental COVID-19 Vaccine Called ‘PittCoVacc’ Works on Mice
University of Pittsburgh School of Medicine researcher scientists have a potential vaccine targeting SARS-CoV-2. Pre-clinical research on mice reveal that the fingerprint-sized patch produces antibodies specific to the novel coronavirus at quantities thought to be...
Observational Research Attempts to Connect TB Vaccination & Severity of COVID-19
A recent non-controlled, observational study led by researchers at the New York Institute of Technology (NYIT) reports that a Bacillus Calmette-Guerin (BCG) vaccine administered after birth to protect against tuberculosis may represent a “game changer” in the fight...
State of Utah Novel Drug Cost Reduction Initiative: Send Employees to Mexico for Radical Reduction in Costs
The State of Utah has created a novel program to lower drug prices for its public sector employees: send them to Mexico. For one state employee, it is a difference of $450 per months versus $2,400 per month. The math is easy. What’s going on? The Utah Program Created...
Regeneron Leverages its Technology Platform, Process and People in the Hopes of Having A COVID-19 Therapy in Trials by Summer
Regeneron and its “VELOCISUITE®” platform was used to develop a treatment for Ebola (REGN-EB3), currently used by the Congolese government to fight that horrific virus. The New York State-based venture has, like many biopharma companies, dedicated a full force...
Cell Therapy Biotech Venture Raises $150m Series A Financing
Legend Biotech Corporation (Legend), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, raised $150 million in Series A financing. The capital infusion will go toward...
Merck’s Keytruda Hits Coprimary Endpoint Early in MSI-H or dMMR Colorectal Cancer Trial
Merck announced interim results from the Phase 3 KEYNOTE-177 trial evaluating first-line treatment of Keytruda in patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) unresectable or metastatic colorectal cancer. Interim data shows...
When the Taylors met Dr. Lopez de Castilla, the Possible Occurred Against COVID-19
Josie and George Taylor, 74 and 76 respectively, have been married for almost 52 years and most recently faced one of their biggest challenges in over half a century: COVID-19. After the two recovered while at EvergreenHealth medical center, they were approached by a...
Pharma Drama: bluebird bio, Inc. Directors Accused of “Grossly Excessive” Compensation While separate Errant Gene Therapeutics Lawsuit Heads for Trial
In new twists on a convoluted tale of medicine and money, a shareholder lawsuit against bluebird bio, Inc.’s (formerly Genetix) directors is accusing them of overpaying themselves, as other litigation moves forward. bluebird bio has been featured on our site in the...
